119-hr3674

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3674 Introduced in House

    (IH) ]

<DOC>

119th CONGRESS
 1st Session
 H. R. 3674

 To authorize United States participation in the Davos Alzheimer's 
 Collaborative.

_______________________________________________________________________

 IN THE HOUSE OF REPRESENTATIVES

 June 3, 2025

 Mr. Bera (for himself, Mr. Fitzpatrick, and Mrs. Kim) introduced the 
 following bill; which was referred to the Committee on Foreign Affairs

_______________________________________________________________________

 A BILL

 To authorize United States participation in the Davos Alzheimer's 
 Collaborative.

 Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

 This Act may be cited as the ``Global Alzheimer's Initiative Now 
Act''.

SEC. 2. FINDINGS.

 Congress finds the following:

    (1) Alzheimer's disease and dementia currently afflicts 
 nearly 60 million people across the globe, a number that is 
 projected to jump to more than 150 million by 2050.

    (2) There are now more global cases of Alzheimer's disease 
 and dementia than cancer and HIV combined, with 39 million 
 diagnosed cases of HIV/AIDS and 20 million cases of cancer in 
 2022.

    (3) The pace of populations aging will challenge countries' 
 sovereign funds and health and social safety systems.

    (4) By 2050, the world's population of people aged 60 years 
 and older will double to 1.6 billion and reach a proportion of 
 22 percent of the world's population. While the number of 
 persons aged 80 or older is expected to triple by 2050.

    (5) The old-age dependency ratio, expressing the relative 
 size of the older population compared with the working-age 
 population, is projected to more than double by 2075 in the 
 majority of the world. Rising dependency ratios will result in 
 increasing pressures on old-age support systems, with fewer 
 people of working age for each older person.

    (6) The prevalence of Alzheimer's disease and dementia is 
 growing most rapidly in low- and middle-income countries, which 
 comprise more than 70 percent of the world's Alzheimer's 
 disease and dementia cases.

    (7) Every year, Alzheimer's disease and dementia costs the 
 global economy more than $1.3 trillion and this is doubling 
 every decade.

    (8) By 2050, the number of Americans living with 
 Alzheimer's disease and dementia is expected to reach 12.7 
 million, bringing the total cost to nearly $1 trillion each 
 year, with minority populations in the United States 
 disproportionately impacted by these trends.

    (9) International Alzheimer's research across all races and 
 ethnicities directly benefits minority populations in the 
 United States.

    (10) Women are disproportionately affected by Alzheimer's 
 disease and dementia, both directly and indirectly. Women 
 experience higher disability-adjusted life years and mortality 
 due to Alzheimer's disease and dementia, but also provide 70 
 percent of care hours for people living with Alzheimer's 
 disease and dementia.

    (11) The Davos Alzheimer's Collaborative

    (DAC) is a public-
 private-patient venture, launched in 2021, that is transforming 
 Alzheimer's disease and dementia research, prevention, and care 
 in low-income, middle-income, and high-income settings 
 globally.

    (12) DAC seeks to raise and deploy over $700 million over 6 
 years to accelerate innovation in drug development and 
 transform the way healthcare systems prevent, diagnose, and 
 treat Alzheimer's disease and dementia for all people in all 
 places.

    (13) In 2023, DAC supported 19 healthcare systems in 12 
 countries, including the United States.

    (14) The United States Government has traditionally been 
 the largest funder of global health programs, with 
 approximately $12 billion in funding in fiscal year 2024 for 
 programs that cover the full range of global health challenges.

    (15) The United States Government has been a lead funder of 
 multilateral health initiatives, such as Gavi, the Vaccine 
 Alliance, the Global Fund to Fight AIDS, TB and Malaria, the 
 Coalition for Epidemic Preparedness Innovations, and the 
 International AIDS Vaccine Initiative.

SEC. 3. STATEMENT OF POLICY.

 It shall be the policy of the United States--

    (1) to lead global cooperative efforts to combat 
 Alzheimer's disease and dementia, including in countries with 
 low-income economies and countries with middle-income economies 
 (as such terms are defined by the World Bank) that represent 
 the majority of future cases; and

    (2) to lead multilateral health initiatives, including the 
 Davos Alzheimer's Collaborative--
        (A) to develop diagnostics and treatments for 
 diverse populations in the United States and across the 
 globe;
        (B) to promote international development 
 cooperation; and
            (C) to provide substantial leverage and burden 
 sharing for United States investments.

SEC. 4. AUTHORIZATION FOR UNITED STATES PARTICIPATION IN THE DAVOS 
 ALZHEIMER'S COLLABORATIVE.

    (a) In General.--The United States is hereby authorized to 
participate in, and contribute to, the Davos Alzheimer's Collaborative

    (DAC) in order to advance international efforts to prevent, diagnose, 
and treat Alzheimer's disease and dementia.

    (b) Designee.--

    (1) In general.--The President is authorized to designate 
 an employee of the relevant Federal department or agency 
 providing the majority of United States contributions to DAC to 
 serve on the Advisory Council of DAC and, if nominated, on the 
 Board of Directors of DAC, as a representative of the United 
 States.

    (2) Qualifications.--The individual to be designated 
 pursuant to paragraph

    (1) should demonstrate knowledge and 
 experience in the fields of development and public health.

    (3) Cooperation.--In carrying out this section, the 
 individual designated pursuant to paragraph

    (1) shall 
 coordinate with the USAID Administrator, the Secretary of 
 State, and the Secretary of Health and Human Services to 
 promote alignment, as appropriate, between DAC and United 
 States global health and Alzheimer's disease and dementia 
 research and development programs.
            (c) United States Contributions.--

    (1) In general.--Amounts authorized to be appropriated and 
 made available to carry out chapters 1 and 10 of part I and 
 chapter 4 of part II of the Foreign Assistance Act of 1961 (22 
 U.S.C. 2151 et seq.) are authorized to be made available for 
 United States contributions to DAC.

    (2) Matching requirement.--Amounts made available under 
 paragraph

    (1) may be obligated and expended only to the extent 
 that DAC secures funding from sources other than the United 
 States. At any time during fiscal years 2026 through 2030, no 
 United States contribution to DAC may cause the total amount of 
 United States Government contributions to DAC to exceed 33 
 percent of the total amount of funds contributed to the DAC 
 from all sources.
            (d) Report.--Not later than 180 days after the date of the 
enactment of this Act, and on an annual basis thereafter, the President 
shall submit to the appropriate congressional committees a report that 
includes the following:

    (1) A description of any planned financial contributions 
 from the United States Government to DAC.

    (2) The manner and extent to which the United States will 
 participate in the governance of DAC.

    (3) A summary of private and governmental contributions to 
 DAC.

    (4) A description of how participation in DAC supports 
 relevant United States Government strategies and programs to 
 combat Alzheimer's disease and dementia and to promote global 
 health.

    (e) 

=== Definition. ===
-In subsection
            (d) , the term ``appropriate 
congressional committees'' means--

    (1) the Committee on Foreign Affairs and Committee on 
 Appropriations of the House of Representatives; and

    (2) the Committee on Foreign Relations and the Committee on 
 Appropriations of the Senate.
 <all>